Catalyst Wire Dossier Catalyst Wire Dossier

Naproxen sodium extended-release 660 mg tablet

naproxen sodium · Bayer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Naproxen sodium extended-release 660 mg tablet, covering 2015-09-15 to 2015-09-15. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence of Single Dose Extended Release Naproxen Sodium (660 mg) Tablet Versus Naproxen Sodium (220 mg) Tablet Three Times Daily [Phase 1]

See pricing